Sangamo gene therapy shows promise in reducing HIV

An early stage trial of Sangamo BioSciences Inc's HIV treatment found that the gene therapy reduced levels of the virus and even eliminated it in one patient with a naturally occurring gene mutation. The very small Phase 1 trial tested the SB-728-T gene therapy, which is designed to disrupt the CCR5 ...

Related News:-

• Zinc Finger Proteins Put Personalized HIV Therapy Within Reach


Zinc Finger Proteins Put Personalized HIV Therapy Within Reach - A moderated community forum for people living with and at risk for HIV/AIDS to ask questions about HIV/AIDS ...

• Triple-punch gene therapy targets HIV: Scientific American


Stem-cell transplant passes safety trial. ... Triple-punch gene therapy targets HIV. Stem-cell transplant passes safety trial.

• Gene Therapy Costs - a comprehensive view - Wellsphere


Expert articles, personal stories, blogs, Q&A, news, local resources, pictures, video and a supportive community. Gene Therapy Costs - Health Knowledge Made Personal.

• Biology News: Triple-punch gene therapy targets HIV


Developed by Baylor College of Medicine, BioEd Online provides up-to-date teacher resources for biology educators. Site features include: a PowerPoint slide library, stream video ...

• Triple-punch gene therapy targets HIV


A combination gene therapy that endows human stem cells with three ways to resist HIV has passed its first safety test in humans. Four patients with AIDS who were infused with ...

• Sangamo BioSciences Announces Presentation of Positive Clinical ...


First Steps in Development of a Functional Cure for HIV AIDS Demonstration of Successful Engraftment and Expansion of ZFN- CCR5-Modified T-Cell Product, SB-728-

• Great News! – Triple-punch gene therapy targets HIV « PozzieBoy


Stem-cell transplant passes safety trial. Alla Katsnelson. HIV (pictured) can find it hard to invade stem cells whose defences are bolstered by gene therapy.photodisc ...

• Here's the repost of the 100 reasons to own Sangamo | SGMO Message ...


Sangamo BioSciences Inc. Message board - Online Community of active, educated investors researching and discussing Sangamo BioSciences Inc. Stocks.

• Blog Stories


The development of gene therapy, a method of correcting defective genes that cause disease, has been a long and difficult road for scientific researchers.